OCT 23, 2026 · JOURNAL ARTICLE
T Cell Receptor–Engineered T Cell Therapy in Solid Tumors: Where We Stand and What's to Come
Annual Review of Medicine
T cell receptor–engineered T (TCR-T) cell therapy has emerged as a promising adoptive cellular therapy for solid tumors by enabling recognition of intracellular antigens presented